some diseases may cause the body's failure to metabolize or utilize Vitamin D very well. Patients with kidney disease are often unable to convert Vitamin D very well into its active form, which makes ...
(Nasdaq: CVKD), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) anticoagulant ... treatment options for patients with LVADs and rare cardiovascular ...